Chen, Yi-Bin <br/><br/>
Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.  [electronic resource] 

 -  Blood advances  03 2019 
 - 875-883 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2018027599  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD34--analysis<br/>Benzylamines<br/>Cyclams<br/>Hematologic Neoplasms--therapy<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Heterocyclic Compounds--therapeutic use<br/>Histocompatibility<br/>Humans<br/>Middle Aged<br/>Siblings<br/>Tissue Donors<br/>Transplantation, Homologous<br/>Treatment Outcome